Arizona Man Who Received Heart Device Dies
TUCSON, Ariz-An Arizona man who received an experimental heart device last week at University Medical Center in Tucson has died from a lung infection.
William Mackay, 66, died at the hospital after developing the infection during surgery last Wednesday. The infection spread from his lungs into the blood stream, and eventually through his entire body.
The LionHeart device has been implanted in 17 people, including five in the US. Mackay is believed to be the first to have died after the procedure. The LionHeart device is unique because it is a completely internal system of pumping of the heart. Current systems use external power sources.
Mackay, who was suffering from end-stage heart failure, had a few months to live when he received the device.
Source: www.arizonarepublic.com
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
